Evidence map›Paper›PMID 35793869›Full record

ArticleJournal for immunotherapy of cancer2022

Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature.

Abigail Wong-Rolle, Qiang Dong, Yunhua Zhu, Prajan Divakar, Jyh Liang Hor, Noemi Kedei, Madeline Wong, Desiree Tillo, Elizabeth A Conner, Arun Rajan and 4 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Journal for immunotherapy of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00242723 recruitingnot on this map

Prospective Evaluation of Genetic and Epigenetic Alterations in Patients With Thoracic Malignancies

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2005Enrolled1,559ConditionsThoracic Cancers, Malignant Pleural Mesotheliomas NOS, Lung Cancer NOS, Esophageal Cancers NOS
NCT02146170 recruitingnot on this map

Tissue Procurement and Natural History Study of Patients With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2014 to 2029Enrolled2,000ConditionsNon-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Abigail Wong-RolleThoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.
Qiang DongPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Yunhua ZhuBioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, NIAID, Bethesda, Maryland, USA.
Prajan DivakarNanoString Technologies Inc, Seattle, Washington State, USA.
Jyh Liang HorLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, Bethesda, Maryland, USA.
Noemi KedeiCollaborative Protein Technology Resource, NCI, Bethesda, Maryland, USA.
Madeline WongCCR Genomics Core, National Cancer Institute, Bethesda, Maryland, USA.
Desiree TilloCCR Genomics Core, National Cancer Institute, Bethesda, Maryland, USA.
Elizabeth A ConnerCCR Genomics Core, National Cancer Institute, Bethesda, Maryland, USA.
Arun RajanThoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0003-2776-3385
David S SchrumpThoracic Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
Chengcheng JinPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ronald N GermainLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, Bethesda, Maryland, USA.
Chen ZhaoThoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA chen.zhao@nih.gov.ORCID 0000-0002-1494-5983
National Cancer Institute · USUniversity of Pennsylvania · USFrederick National Laboratory for Cancer Research · USNanostring Technologies (United States) · USNaval Research Laboratory Information Technology Division

Funding

Multiscale Analysis of Immune ResponsesZIAAI000545 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GERMAIN, RONALD N · 2009 to 2025
$29.4M
CCR Genomics CoreZICBC011623 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CONNER, ELIZABETH · 2015 to 2025
$20.5M
Modulating Cancer Stem Cell Signaling in Thoracic MalignanciesZIABC011418 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHRUMP, DAVID · 2011 to 2025
$17.4M
Spatial Imaging Technology ResourceZICBC011434 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MALIK, MARIAM · 2012 to 2025
$12.8M
Study interactions between lung microbiota and immune cells in NSCLCZIABC012008 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ZHAO, CHEN · 2020 to 2025
$3.1M
Investigate heterogeneous neutrophils in NSCLCZIABC012011 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ZHAO, CHEN · 2020 to 2023
$1.1M
Investigating immune-microbiota interaction in lung cancerR00CA226400 · NCI · UNIVERSITY OF PENNSYLVANIA · PI JIN, CHENGCHENG · 2020 to 2022
$866k
Anti-PD-L1-TGFb antibody (M7824) in advanced Non-Small Cell Lung CancerZIABC011905 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RAJAN, ARUN · 2019 to 2025
$817k
Investigating immune-microbiota interaction in lung cancerK99CA226400 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JIN, CHENGCHENG · 2018 to 2019
$252k
NCI NIH HHS K99 CA226400NCI NIH HHS R00 CA226400
6 · The paper itself

Abstract

backgroundThe lung intratumor microbiome influences lung cancer tumorigenesis and treatment responses, but detailed data on the extent, location, and effects of microbes within lung tumors are missing, information needed for improved prognosis and treatment.

methodsTo address this gap, we developed a novel spatial meta-transcriptomic method simultaneously detecting the expression level of 1,811 host genes and 3 microbe targets (bacteria, fungi, and cytomegalovirus). After rigorous validation, we analyzed the spatial meta-transcriptomic profiles of tumor cells, T cells, macrophages, other immune cells, and stroma in surgically resected tumor samples from 12 patients with early-stage lung cancer.

resultsBacterial burden was significantly higher in tumor cells compared with T cells, macrophages, other immune cells, and stroma. This burden increased from tumor-adjacent normal lung and tertiary lymphoid structures to tumor cells to the airways, suggesting that lung intratumor bacteria derive from the latter route of entry. Expression of oncogenic β-catenin was strongly correlated with bacterial burden, as were tumor histological subtypes and environmental factors.

conclusionsIntratumor bacteria were enriched with tumor cells and associated with multiple oncogenic pathways, supporting a rationale for reducing the local intratumor microbiome in lung cancer for patient benefit. TRIAL REGISTRATION NUMBER: NCT00242723, NCT02146170.

Indexed as

Lung NeoplasmsTranscriptomeBacteriaCarcinogenesisHumansLunglung neoplasmstranslational medical researchtumor microenvironment

Identifiers

PMID35793869
PMCPMC9260850
OpenAlexW4284887125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.